Mdr P-glycoproteins are not essential for biliary excretion of the hydrophobic heme precursor protoporphyrin in a griseofulvin-induced mouse model of erythropoietic protoporphyria

Hepatology

Volumn 35, Issue 2, 2002, Pages 299-306

  Plösch, Torsten ^a   Bloks, Vincent W ^a   Baller, Juul F W ^a   Havinga, Rick ^a   Verkade, Henkjan J ^a   Jansen, Peter L M ^b   Kuipers, Folkert ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLYCOPROTEIN P; GRISEOFULVIN; HEME; PHOSPHOLIPID; PROTOPORPHYRIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE FLOW; BILIARY EXCRETION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ERYTHROPOIETIC PROTOPORPHYRIA; GENE DISRUPTION; HYDROPHOBICITY; LIVER DISEASE; MALE; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN LOCALIZATION;

EID: 0036156749     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2002.30900     Document Type: Article

References (42)

1. The Porphyrias
2. Molecular defects in ferrochelatase in patients with protoporphyria requiring liver transplantation
3. Mechanisms of photosensitivity in porphyric patients with special emphasis on erythropoietic protoporphyria
4. The liver in protoporphyria
5. Erythropoietic protoporphyria
6. Erythropoietic protoporphyria
7. Relationship between biliary lipid and protoporphyrin secretion; potential role of mdr2 P-glycoprotein in hepatobiliary organic anion transport
8. Mechanism of bile acid facilitation of biliary protoporphyrin excretion in rat liver
9. Erythropoietic protoporphyria in the house mouse. A recessive inherited ferrochelatase deficiency with anemia, photosensitivity, and liver disease
10. Stimulation of the pathway of porphyrin synthesis in the liver of rats and mice by griseofulvin, 3,5-Diethoxycarbonyl-1,4-dihydrocollidine and related drugs: Evidence for two basically different mechanisms
11. Toxic effects of griseofulvin: Disease models, mechanisms, and risk assessment
12. Occurrence and biological properties of N-methyl protoporphyrin
13. Isolation of two N-monosubstituted protoporphyrins, bearing either the whole drug or a methyl group on the pyrrole nitrogen atom, from liver of mice given griseofulvin
14. Experimental Mallory body formation is accompanied by modulation of the expression of multidrug-resistance genes and their products
15. Hyperlipidemia and atherosclerosis associated with liver disease in ferrochelatase-deficient mice
16. Homozygous disruption of the murine mdr2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
17. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine
18. Biochemical, cellular, and pharmacological aspects of the multidrug transporter
19. MDR3 P-glycoprotein, a phosphatidylcholine translocase, transports several cytotoxic drugs and directly interacts with drugs as judged by interference with nucleotide trapping
20. Reduced plasma cholesterol and increased fecal sterol loss in multidrug resistance gene 2 P-glycoproteindeficient mice
21. A fluorimetric and enzymatic method for the estimation of serum total bile acids
22. A rapid method of total lipid extraction and purification
23. A rapid and sensitive sub-micro phosphorus determination
24. Procedure for determination of free and total cholesterol in micro- or nanogram amounts suitable for studies with cultured cells
25. Overexpression of the multidrug resistance genes mdr1, mdr3, and mrp in L1210 leukemia cells resistant to inhibitors of ribonucleotide reductase
26. A rapid and versatile method to synthesize internal standards for competitive PCR
27. Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
28. Protoporphyria
29. Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria
30. Ultrastructural changes of intrahepatic bile ductules in griseofulvin fed mice
31. Hypercholesterolaemia and liver enlargement in experimental hepatic porphyria
32. Biochemistry and clinical relevance of lipoprotein X
33. Class III P-glycoproteins mediate the formation of lipoprotein X in the mouse
34. Correlation of 14C-griseofulvin metabolism in rat liver microsomes, isolated perfused rat livers, and in rats with bile duct cannulas
35. Bile secretion and liver microsomal mixed function oxidase system in mice with griseofulvin-induced hepatic protoporphyria
36. Enzyme-histochemical studies of griseofulvin-intoxicated mouse livers
37. Griseofulvin-induced hepatopathy due to abnormalities in heme pathway
38. On the metabolism of lipoprotein-X (LP-X)
39. Structural alterations in lecithincholesterol vesicles following interactions with monomeric and micellar bile salts: Physical-chemical basis for subselection of biliary lecithin species and aggregative states of biliary lipids during bile formation
40. Bile salt hydrophobicity controls vesicle secretion rates and transformations in native bile
41. Cholesterol carriers in human bile: Are "lamellae" involved?
42. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes